ロード中...
Metabolic Changes During Gonadotropin-releasing Hormone Agonist Therapy for Prostate Cancer: Differences From the Classic Metabolic Syndrome
BACKGROUND: In men with prostate cancer, gonadotropin-releasing hormone (GnRH) agonists increase fat mass, decrease insulin sensitivity, and increase triglycerides, features that are shared with metabolic syndrome. To the authors’ knowledge, however, less is known regarding the effects of GnRH agoni...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2562782/ https://ncbi.nlm.nih.gov/pubmed/18348297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23440 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|